General Information of Drug (ID: DMICR39)

Drug Name
XL784
Indication
Disease Entry ICD 11 Status REF
Diabetic nephropathy GB61.Z Discontinued in Phase 2 [1]
ADMET Property
Absorption
The drug is orally available []
Half-life
The concentration or amount of drug in body reduced by one-half in 8 hours [2]
Cross-matching ID
DrugBank ID
DB04991
TTD ID
D0G4OT

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Matrix metalloproteinase-1 (MMP-1) TTMX39J MMP1_HUMAN Inhibitor [1]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 Agents in development for the treatment of diabetic nephropathy. Expert Opin Emerg Drugs. 2008 Sep;13(3):447-63.
2 Trend Analysis of a Database of Intravenous Pharmacokinetic Parameters in Humans for 1352 Drug Compounds